Cargando…
Treatment of corticosteroid refractory immune checkpoint inhibitor myocarditis with Infliximab: a case series
BACKGROUND: Glucocorticoid treatment remains the cornerstone of therapy for immune checkpoint inhibitor (ICI) myocarditis, but data supporting the use of additional immunotherapy for steroid refractory cases remains limited. We investigate the safety and efficacy of infliximab in patients with ICI m...
Autores principales: | Zhang, Robert S., Padegimas, Allison, Murphy, Kathleen M., Evans, Peter T., Peters, Carli J., Domenico, Christopher M., Vidula, Mahesh K., Mather, Paul J., Cevasco, Marisa, Cohen, Roger B., Carver, Joseph R., O’Quinn, Rupal P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8008661/ https://www.ncbi.nlm.nih.gov/pubmed/33785062 http://dx.doi.org/10.1186/s40959-021-00095-x |
Ejemplares similares
-
Clinical outcomes of patients with corticosteroid refractory immune checkpoint inhibitor-induced enterocolitis treated with infliximab
por: Alexander, James L, et al.
Publicado: (2021) -
Tocilizumab for refractory severe immune checkpoint inhibitor-associated myocarditis
por: Doms, J., et al.
Publicado: (2020) -
Vedolizumab Attenuates Immune-Checkpoint-Therapy-Induced Infliximab-Refractory Colitis
por: Kaneoka, Ayaka, et al.
Publicado: (2022) -
Infliximab for Steroid-Refractory Immune Checkpoint Inhibitor-Induced Acute Pancreatitis
por: Townsend, Matthew J., et al.
Publicado: (2023) -
How to Diagnose and Manage Patients With Fluoropyrimidine-Induced Chest Pain: A Single Center Approach
por: Padegimas, Allison, et al.
Publicado: (2020)